Oppenheimer Upgrades Crescent Capital BDC to Outperform, Lowers Price Target to $19

Oppenheimer analyst Mitchel Penn upgrades Crescent Capital BDC (NASDAQ:CCAP) from Perform to Outperform and lowers the price target from $20 to $19.

Oppenheimer analyst Mitchel Penn upgrades Crescent Capital BDC (NASDAQ:CCAP) from Perform to Outperform and lowers the price target from $20 to $19.

Total
0
Shares
Related Posts